Effects of Gender-Affirming Hormone Therapy Among Transgender Women

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Transgender WomenHIV/AIDSCardiovascular DiseasesMetabolic DiseaseCoagulopathy
Interventions
OTHER

Abdominal MR Imaging

Imaging to evaluate visceral adipose tissue and hepatic lipid content

OTHER

Cardiac MRI/MRS

Imaging to evaluate cardiac function and structure

OTHER

Oral Glucose Tolerance Testing

Blood testing to evaluate changes in glucose and insulin in response to oral glucose load

OTHER

Whole Body, Lumbar Spine, and Hip DEXA Imaging

Imaging to evaluate fat and lean body mass as well as bone mineral density

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

collaborator

American Heart Association

OTHER

collaborator

Robert Wood Johnson Foundation

OTHER

lead

Massachusetts General Hospital

OTHER

NCT04128488 - Effects of Gender-Affirming Hormone Therapy Among Transgender Women | Biotech Hunter | Biotech Hunter